These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1121 related articles for article (PubMed ID: 32222610)

  • 1. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
    Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cachexia: molecular mechanism and pharmacological management.
    Li Y; Jin H; Chen Y; Huang T; Mi Y; Zou Z
    Biochem J; 2021 May; 478(9):1663-1688. PubMed ID: 33970218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue dysfunction in cancer cachexia.
    Daas SI; Rizeq BR; Nasrallah GK
    J Cell Physiol; 2018 Jan; 234(1):13-22. PubMed ID: 30078199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biochemical basis of metabolism in cancer cachexia.
    Tijerina AJ
    Dimens Crit Care Nurs; 2004; 23(6):237-43. PubMed ID: 15586034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
    Argilés JM; López-Soriano FJ; Busquets S
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Leptin Receptor Antagonist Attenuates Adipose Tissue Browning and Muscle Wasting in Infantile Nephropathic Cystinosis-Associated Cachexia.
    Gonzalez A; Cheung WW; Perens EA; Oliveira EA; Gertler A; Mak RH
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone stimulates adipose tissue browning: a pathway to muscle wasting.
    Thomas SS; Mitch WE
    Curr Opin Clin Nutr Metab Care; 2017 May; 20(3):153-157. PubMed ID: 28257332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On our way to targeted therapy for cachexia in cancer?
    Boddaert MS; Gerritsen WR; Pinedo HM
    Curr Opin Oncol; 2006 Jul; 18(4):335-40. PubMed ID: 16721127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes in the pathogenesis and treatment of cancer-related cachexia.
    Ru Q; Chen L; Xu G; Wu Y
    J Transl Med; 2024 Apr; 22(1):408. PubMed ID: 38689293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome].
    Inui A
    Rinsho Byori; 2006 Oct; 54(10):1044-51. PubMed ID: 17133993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deliberation on debilitating condition of cancer cachexia: Skeletal muscle wasting.
    Dave S; Patel BM
    Fundam Clin Pharmacol; 2023 Dec; 37(6):1079-1091. PubMed ID: 37474262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of cancer cachexia‑induced muscle atrophy (Review).
    Yang W; Huang J; Wu H; Wang Y; Du Z; Ling Y; Wang W; Wu Q; Gao W
    Mol Med Rep; 2020 Dec; 22(6):4967-4980. PubMed ID: 33174001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer cachexia: mediators, signaling, and metabolic pathways.
    Fearon KC; Glass DJ; Guttridge DC
    Cell Metab; 2012 Aug; 16(2):153-66. PubMed ID: 22795476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study.
    Luan Y; Zhang Y; Yu SY; You M; Xu PC; Chung S; Kurita T; Zhu J; Kim SY
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1289-1301. PubMed ID: 35044098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
    Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
    J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia.
    Melstrom LG; Melstrom KA; Ding XZ; Adrian TE
    Histol Histopathol; 2007 Jul; 22(7):805-14. PubMed ID: 17455154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Muscle Regeneration in Cancer-Associated Cachexia.
    Arneson PC; Doles JD
    Trends Cancer; 2019 Oct; 5(10):579-582. PubMed ID: 31706505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cachexia.
    Barber MD; Ross JA; Fearon KC
    Surg Oncol; 1999 Nov; 8(3):133-41. PubMed ID: 11113664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTH/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer.
    Kir S; Komaba H; Garcia AP; Economopoulos KP; Liu W; Lanske B; Hodin RA; Spiegelman BM
    Cell Metab; 2016 Feb; 23(2):315-23. PubMed ID: 26669699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer cachexia pathophysiology and translational aspect of herbal medicine.
    Suzuki H; Asakawa A; Amitani H; Fujitsuka N; Nakamura N; Inui A
    Jpn J Clin Oncol; 2013 Jul; 43(7):695-705. PubMed ID: 23737606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.